As the UK prepares to embark on a new path outside of the EU, we will need the best policies and resources to foster open innovation, the “outside in/inside out” flow of ideas that was a contrast to previously closed R&D corporate labs. This is why ‘Open for Innovation’ is our theme for this year’s UK Biopharma R&D Sourcebook. The Sourcebook aims to provide a snapshot of some of the key measures by which our industry develops medicines and the context in which this takes place. We have this data grouped in four sections: Global health and the role of biopharma, Investing in innovation, Driving clinical research to deliver medicines, and Collaborating for innovation. Please note: a higher resolution version of this report (19MB) is also available to download from the right hand side.